0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sexual Dysfunction Drugs Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-20I7098
Home | Market Reports | Health| Reproductive Health
Global Sexual Dysfunction Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Sexual Dysfunction Drugs Market Research Report 2024

Code: QYRE-Auto-20I7098
Report
February 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sexual Dysfunction Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Sexual Dysfunction Drugs Market

Sexual Dysfunction Drugs Market

Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.
The global Sexual Dysfunction Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sexual Dysfunction Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexual Dysfunction Drugs.

Report Scope

The Sexual Dysfunction Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sexual Dysfunction Drugs market comprehensively. Regional market sizes, concerning products by Type, by User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sexual Dysfunction Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by User, and by regions.
Market Segmentation

Scope of Sexual Dysfunction Drugs Market Report

Report Metric Details
Report Name Sexual Dysfunction Drugs Market
CAGR 5%
Segment by Type
  • Oral Therapy
  • Intracavernosal Therapy
  • Hormonal Therapy
  • Transurethral Therapy
Segment by User
  • Male
  • Female
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, GlaxoSmithKline, Merck, Eli Lilly, AbbVie, Bayer, Teva Pharmaceutical Industries, Takeda, Apricus Biosciences, Emotional Brain, Ivix LLX, Leadiant Biosciences, NexMed, S1 Biopharma, Vietstar Biomedical Research
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sexual Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sexual Dysfunction Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sexual Dysfunction Drugs Market report?

Ans: The main players in the Sexual Dysfunction Drugs Market are Pfizer, GlaxoSmithKline, Merck, Eli Lilly, AbbVie, Bayer, Teva Pharmaceutical Industries, Takeda, Apricus Biosciences, Emotional Brain, Ivix LLX, Leadiant Biosciences, NexMed, S1 Biopharma, Vietstar Biomedical Research

What are the Type segmentation covered in the Sexual Dysfunction Drugs Market report?

Ans: The Types covered in the Sexual Dysfunction Drugs Market report are Oral Therapy, Intracavernosal Therapy, Hormonal Therapy, Transurethral Therapy

1 Sexual Dysfunction Drugs Market Overview
1.1 Product Overview and Scope of Sexual Dysfunction Drugs
1.2 Sexual Dysfunction Drugs Segment by Type
1.2.1 Global Sexual Dysfunction Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral Therapy
1.2.3 Intracavernosal Therapy
1.2.4 Hormonal Therapy
1.2.5 Transurethral Therapy
1.3 Sexual Dysfunction Drugs Segment by User
1.3.1 Global Sexual Dysfunction Drugs Market Value by User: (2024-2030)
1.3.2 Male
1.3.3 Female
1.4 Global Sexual Dysfunction Drugs Market Size Estimates and Forecasts
1.4.1 Global Sexual Dysfunction Drugs Revenue 2019-2030
1.4.2 Global Sexual Dysfunction Drugs Sales 2019-2030
1.4.3 Global Sexual Dysfunction Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sexual Dysfunction Drugs Market Competition by Manufacturers
2.1 Global Sexual Dysfunction Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sexual Dysfunction Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sexual Dysfunction Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Sexual Dysfunction Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sexual Dysfunction Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sexual Dysfunction Drugs, Product Type & Application
2.7 Sexual Dysfunction Drugs Market Competitive Situation and Trends
2.7.1 Sexual Dysfunction Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sexual Dysfunction Drugs Players Market Share by Revenue
2.7.3 Global Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sexual Dysfunction Drugs Retrospective Market Scenario by Region
3.1 Global Sexual Dysfunction Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sexual Dysfunction Drugs Global Sexual Dysfunction Drugs Sales by Region: 2019-2030
3.2.1 Global Sexual Dysfunction Drugs Sales by Region: 2019-2024
3.2.2 Global Sexual Dysfunction Drugs Sales by Region: 2025-2030
3.3 Global Sexual Dysfunction Drugs Global Sexual Dysfunction Drugs Revenue by Region: 2019-2030
3.3.1 Global Sexual Dysfunction Drugs Revenue by Region: 2019-2024
3.3.2 Global Sexual Dysfunction Drugs Revenue by Region: 2025-2030
3.4 North America Sexual Dysfunction Drugs Market Facts & Figures by Country
3.4.1 North America Sexual Dysfunction Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sexual Dysfunction Drugs Sales by Country (2019-2030)
3.4.3 North America Sexual Dysfunction Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sexual Dysfunction Drugs Market Facts & Figures by Country
3.5.1 Europe Sexual Dysfunction Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sexual Dysfunction Drugs Sales by Country (2019-2030)
3.5.3 Europe Sexual Dysfunction Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sexual Dysfunction Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Sexual Dysfunction Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sexual Dysfunction Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Sexual Dysfunction Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Sexual Dysfunction Drugs Market Facts & Figures by Country
3.7.1 Latin America Sexual Dysfunction Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sexual Dysfunction Drugs Sales by Country (2019-2030)
3.7.3 Latin America Sexual Dysfunction Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sexual Dysfunction Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Sexual Dysfunction Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sexual Dysfunction Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sexual Dysfunction Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sexual Dysfunction Drugs Sales by Type (2019-2030)
4.1.1 Global Sexual Dysfunction Drugs Sales by Type (2019-2024)
4.1.2 Global Sexual Dysfunction Drugs Sales by Type (2025-2030)
4.1.3 Global Sexual Dysfunction Drugs Sales Market Share by Type (2019-2030)
4.2 Global Sexual Dysfunction Drugs Revenue by Type (2019-2030)
4.2.1 Global Sexual Dysfunction Drugs Revenue by Type (2019-2024)
4.2.2 Global Sexual Dysfunction Drugs Revenue by Type (2025-2030)
4.2.3 Global Sexual Dysfunction Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Sexual Dysfunction Drugs Price by Type (2019-2030)
5 Segment by User
5.1 Global Sexual Dysfunction Drugs Sales by User (2019-2030)
5.1.1 Global Sexual Dysfunction Drugs Sales by User (2019-2024)
5.1.2 Global Sexual Dysfunction Drugs Sales by User (2025-2030)
5.1.3 Global Sexual Dysfunction Drugs Sales Market Share by User (2019-2030)
5.2 Global Sexual Dysfunction Drugs Revenue by User (2019-2030)
5.2.1 Global Sexual Dysfunction Drugs Revenue by User (2019-2024)
5.2.2 Global Sexual Dysfunction Drugs Revenue by User (2025-2030)
5.2.3 Global Sexual Dysfunction Drugs Revenue Market Share by User (2019-2030)
5.3 Global Sexual Dysfunction Drugs Price by User (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Sexual Dysfunction Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GlaxoSmithKline Sexual Dysfunction Drugs Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Sexual Dysfunction Drugs Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Corporation Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly Sexual Dysfunction Drugs Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbbVie Sexual Dysfunction Drugs Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer Sexual Dysfunction Drugs Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Teva Pharmaceutical Industries
6.6.1 Teva Pharmaceutical Industries Corporation Information
6.6.2 Teva Pharmaceutical Industries Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Portfolio
6.7.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.8 Takeda
6.8.1 Takeda Corporation Information
6.8.2 Takeda Description and Business Overview
6.8.3 Takeda Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Takeda Sexual Dysfunction Drugs Product Portfolio
6.8.5 Takeda Recent Developments/Updates
6.9 Apricus Biosciences
6.9.1 Apricus Biosciences Corporation Information
6.9.2 Apricus Biosciences Description and Business Overview
6.9.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Apricus Biosciences Sexual Dysfunction Drugs Product Portfolio
6.9.5 Apricus Biosciences Recent Developments/Updates
6.10 Emotional Brain
6.10.1 Emotional Brain Corporation Information
6.10.2 Emotional Brain Description and Business Overview
6.10.3 Emotional Brain Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Emotional Brain Sexual Dysfunction Drugs Product Portfolio
6.10.5 Emotional Brain Recent Developments/Updates
6.11 Ivix LLX
6.11.1 Ivix LLX Corporation Information
6.11.2 Ivix LLX Sexual Dysfunction Drugs Description and Business Overview
6.11.3 Ivix LLX Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Ivix LLX Sexual Dysfunction Drugs Product Portfolio
6.11.5 Ivix LLX Recent Developments/Updates
6.12 Leadiant Biosciences
6.12.1 Leadiant Biosciences Corporation Information
6.12.2 Leadiant Biosciences Sexual Dysfunction Drugs Description and Business Overview
6.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Leadiant Biosciences Sexual Dysfunction Drugs Product Portfolio
6.12.5 Leadiant Biosciences Recent Developments/Updates
6.13 NexMed
6.13.1 NexMed Corporation Information
6.13.2 NexMed Sexual Dysfunction Drugs Description and Business Overview
6.13.3 NexMed Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 NexMed Sexual Dysfunction Drugs Product Portfolio
6.13.5 NexMed Recent Developments/Updates
6.14 S1 Biopharma
6.14.1 S1 Biopharma Corporation Information
6.14.2 S1 Biopharma Sexual Dysfunction Drugs Description and Business Overview
6.14.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 S1 Biopharma Sexual Dysfunction Drugs Product Portfolio
6.14.5 S1 Biopharma Recent Developments/Updates
6.15 Vietstar Biomedical Research
6.15.1 Vietstar Biomedical Research Corporation Information
6.15.2 Vietstar Biomedical Research Sexual Dysfunction Drugs Description and Business Overview
6.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Vietstar Biomedical Research Sexual Dysfunction Drugs Product Portfolio
6.15.5 Vietstar Biomedical Research Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sexual Dysfunction Drugs Industry Chain Analysis
7.2 Sexual Dysfunction Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sexual Dysfunction Drugs Production Mode & Process
7.4 Sexual Dysfunction Drugs Sales and Marketing
7.4.1 Sexual Dysfunction Drugs Sales Channels
7.4.2 Sexual Dysfunction Drugs Distributors
7.5 Sexual Dysfunction Drugs Customers
8 Sexual Dysfunction Drugs Market Dynamics
8.1 Sexual Dysfunction Drugs Industry Trends
8.2 Sexual Dysfunction Drugs Market Drivers
8.3 Sexual Dysfunction Drugs Market Challenges
8.4 Sexual Dysfunction Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Sexual Dysfunction Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Sexual Dysfunction Drugs Market Value Comparison by User (2024-2030) & (US$ Million)
    Table 3. Global Sexual Dysfunction Drugs Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Sexual Dysfunction Drugs Sales (K Pcs) of Key Manufacturers (2019-2024)
    Table 5. Global Sexual Dysfunction Drugs Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Sexual Dysfunction Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Sexual Dysfunction Drugs Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Sexual Dysfunction Drugs Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Sexual Dysfunction Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Sexual Dysfunction Drugs, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Sexual Dysfunction Drugs, Product Type & Application
    Table 12. Global Key Manufacturers of Sexual Dysfunction Drugs, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Sexual Dysfunction Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexual Dysfunction Drugs as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Sexual Dysfunction Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Sexual Dysfunction Drugs Sales by Region (2019-2024) & (K Pcs)
    Table 18. Global Sexual Dysfunction Drugs Sales Market Share by Region (2019-2024)
    Table 19. Global Sexual Dysfunction Drugs Sales by Region (2025-2030) & (K Pcs)
    Table 20. Global Sexual Dysfunction Drugs Sales Market Share by Region (2025-2030)
    Table 21. Global Sexual Dysfunction Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2019-2024)
    Table 23. Global Sexual Dysfunction Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2025-2030)
    Table 25. North America Sexual Dysfunction Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Sexual Dysfunction Drugs Sales by Country (2019-2024) & (K Pcs)
    Table 27. North America Sexual Dysfunction Drugs Sales by Country (2025-2030) & (K Pcs)
    Table 28. North America Sexual Dysfunction Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Sexual Dysfunction Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Sexual Dysfunction Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Sexual Dysfunction Drugs Sales by Country (2019-2024) & (K Pcs)
    Table 32. Europe Sexual Dysfunction Drugs Sales by Country (2025-2030) & (K Pcs)
    Table 33. Europe Sexual Dysfunction Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Sexual Dysfunction Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Sexual Dysfunction Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Sexual Dysfunction Drugs Sales by Region (2019-2024) & (K Pcs)
    Table 37. Asia Pacific Sexual Dysfunction Drugs Sales by Region (2025-2030) & (K Pcs)
    Table 38. Asia Pacific Sexual Dysfunction Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Sexual Dysfunction Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Sexual Dysfunction Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Sexual Dysfunction Drugs Sales by Country (2019-2024) & (K Pcs)
    Table 42. Latin America Sexual Dysfunction Drugs Sales by Country (2025-2030) & (K Pcs)
    Table 43. Latin America Sexual Dysfunction Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Sexual Dysfunction Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Sexual Dysfunction Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Sexual Dysfunction Drugs Sales by Country (2019-2024) & (K Pcs)
    Table 47. Middle East & Africa Sexual Dysfunction Drugs Sales by Country (2025-2030) & (K Pcs)
    Table 48. Middle East & Africa Sexual Dysfunction Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Sexual Dysfunction Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Sexual Dysfunction Drugs Sales (K Pcs) by Type (2019-2024)
    Table 51. Global Sexual Dysfunction Drugs Sales (K Pcs) by Type (2025-2030)
    Table 52. Global Sexual Dysfunction Drugs Sales Market Share by Type (2019-2024)
    Table 53. Global Sexual Dysfunction Drugs Sales Market Share by Type (2025-2030)
    Table 54. Global Sexual Dysfunction Drugs Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Sexual Dysfunction Drugs Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2019-2024)
    Table 57. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2025-2030)
    Table 58. Global Sexual Dysfunction Drugs Price (USD/Pcs) by Type (2019-2024)
    Table 59. Global Sexual Dysfunction Drugs Price (USD/Pcs) by Type (2025-2030)
    Table 60. Global Sexual Dysfunction Drugs Sales (K Pcs) by User (2019-2024)
    Table 61. Global Sexual Dysfunction Drugs Sales (K Pcs) by User (2025-2030)
    Table 62. Global Sexual Dysfunction Drugs Sales Market Share by User (2019-2024)
    Table 63. Global Sexual Dysfunction Drugs Sales Market Share by User (2025-2030)
    Table 64. Global Sexual Dysfunction Drugs Revenue (US$ Million) by User (2019-2024)
    Table 65. Global Sexual Dysfunction Drugs Revenue (US$ Million) by User (2025-2030)
    Table 66. Global Sexual Dysfunction Drugs Revenue Market Share by User (2019-2024)
    Table 67. Global Sexual Dysfunction Drugs Revenue Market Share by User (2025-2030)
    Table 68. Global Sexual Dysfunction Drugs Price (USD/Pcs) by User (2019-2024)
    Table 69. Global Sexual Dysfunction Drugs Price (USD/Pcs) by User (2025-2030)
    Table 70. Pfizer Corporation Information
    Table 71. Pfizer Description and Business Overview
    Table 72. Pfizer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 73. Pfizer Sexual Dysfunction Drugs Product
    Table 74. Pfizer Recent Developments/Updates
    Table 75. GlaxoSmithKline Corporation Information
    Table 76. GlaxoSmithKline Description and Business Overview
    Table 77. GlaxoSmithKline Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 78. GlaxoSmithKline Sexual Dysfunction Drugs Product
    Table 79. GlaxoSmithKline Recent Developments/Updates
    Table 80. Merck Corporation Information
    Table 81. Merck Description and Business Overview
    Table 82. Merck Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 83. Merck Sexual Dysfunction Drugs Product
    Table 84. Merck Recent Developments/Updates
    Table 85. Eli Lilly Corporation Information
    Table 86. Eli Lilly Description and Business Overview
    Table 87. Eli Lilly Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 88. Eli Lilly Sexual Dysfunction Drugs Product
    Table 89. Eli Lilly Recent Developments/Updates
    Table 90. AbbVie Corporation Information
    Table 91. AbbVie Description and Business Overview
    Table 92. AbbVie Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 93. AbbVie Sexual Dysfunction Drugs Product
    Table 94. AbbVie Recent Developments/Updates
    Table 95. Bayer Corporation Information
    Table 96. Bayer Description and Business Overview
    Table 97. Bayer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 98. Bayer Sexual Dysfunction Drugs Product
    Table 99. Bayer Recent Developments/Updates
    Table 100. Teva Pharmaceutical Industries Corporation Information
    Table 101. Teva Pharmaceutical Industries Description and Business Overview
    Table 102. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 103. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product
    Table 104. Teva Pharmaceutical Industries Recent Developments/Updates
    Table 105. Takeda Corporation Information
    Table 106. Takeda Description and Business Overview
    Table 107. Takeda Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 108. Takeda Sexual Dysfunction Drugs Product
    Table 109. Takeda Recent Developments/Updates
    Table 110. Apricus Biosciences Corporation Information
    Table 111. Apricus Biosciences Description and Business Overview
    Table 112. Apricus Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 113. Apricus Biosciences Sexual Dysfunction Drugs Product
    Table 114. Apricus Biosciences Recent Developments/Updates
    Table 115. Emotional Brain Corporation Information
    Table 116. Emotional Brain Description and Business Overview
    Table 117. Emotional Brain Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 118. Emotional Brain Sexual Dysfunction Drugs Product
    Table 119. Emotional Brain Recent Developments/Updates
    Table 120. Ivix LLX Corporation Information
    Table 121. Ivix LLX Description and Business Overview
    Table 122. Ivix LLX Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 123. Ivix LLX Sexual Dysfunction Drugs Product
    Table 124. Ivix LLX Recent Developments/Updates
    Table 125. Leadiant Biosciences Corporation Information
    Table 126. Leadiant Biosciences Description and Business Overview
    Table 127. Leadiant Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 128. Leadiant Biosciences Sexual Dysfunction Drugs Product
    Table 129. Leadiant Biosciences Recent Developments/Updates
    Table 130. NexMed Corporation Information
    Table 131. NexMed Description and Business Overview
    Table 132. NexMed Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 133. NexMed Sexual Dysfunction Drugs Product
    Table 134. NexMed Recent Developments/Updates
    Table 135. S1 Biopharma Corporation Information
    Table 136. S1 Biopharma Description and Business Overview
    Table 137. S1 Biopharma Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 138. S1 Biopharma Sexual Dysfunction Drugs Product
    Table 139. S1 Biopharma Recent Developments/Updates
    Table 140. Vietstar Biomedical Research Corporation Information
    Table 141. Vietstar Biomedical Research Description and Business Overview
    Table 142. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 143. Vietstar Biomedical Research Sexual Dysfunction Drugs Product
    Table 144. Vietstar Biomedical Research Recent Developments/Updates
    Table 145. Key Raw Materials Lists
    Table 146. Raw Materials Key Suppliers Lists
    Table 147. Sexual Dysfunction Drugs Distributors List
    Table 148. Sexual Dysfunction Drugs Customers List
    Table 149. Sexual Dysfunction Drugs Market Trends
    Table 150. Sexual Dysfunction Drugs Market Drivers
    Table 151. Sexual Dysfunction Drugs Market Challenges
    Table 152. Sexual Dysfunction Drugs Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Sexual Dysfunction Drugs
    Figure 2. Global Sexual Dysfunction Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Sexual Dysfunction Drugs Market Share by Type in 2023 & 2030
    Figure 4. Oral Therapy Product Picture
    Figure 5. Intracavernosal Therapy Product Picture
    Figure 6. Hormonal Therapy Product Picture
    Figure 7. Transurethral Therapy Product Picture
    Figure 8. Global Sexual Dysfunction Drugs Market Value Comparison by User (2024-2030) & (US$ Million)
    Figure 9. Global Sexual Dysfunction Drugs Market Share by User in 2023 & 2030
    Figure 10. Male
    Figure 11. Female
    Figure 12. Global Sexual Dysfunction Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Sexual Dysfunction Drugs Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Sexual Dysfunction Drugs Sales (2019-2030) & (K Pcs)
    Figure 15. Global Sexual Dysfunction Drugs Average Price (USD/Pcs) & (2019-2030)
    Figure 16. Sexual Dysfunction Drugs Report Years Considered
    Figure 17. Sexual Dysfunction Drugs Sales Share by Manufacturers in 2023
    Figure 18. Global Sexual Dysfunction Drugs Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Sexual Dysfunction Drugs Players: Market Share by Revenue in 2023
    Figure 20. Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Sexual Dysfunction Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Sexual Dysfunction Drugs Sales Market Share by Country (2019-2030)
    Figure 23. North America Sexual Dysfunction Drugs Revenue Market Share by Country (2019-2030)
    Figure 24. U.S. Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Sexual Dysfunction Drugs Sales Market Share by Country (2019-2030)
    Figure 27. Europe Sexual Dysfunction Drugs Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Sexual Dysfunction Drugs Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Sexual Dysfunction Drugs Revenue Market Share by Region (2019-2030)
    Figure 35. China Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. China Taiwan Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Sexual Dysfunction Drugs Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Sexual Dysfunction Drugs Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Sexual Dysfunction Drugs Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Sexual Dysfunction Drugs Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE Sexual Dysfunction Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Sexual Dysfunction Drugs by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Sexual Dysfunction Drugs by Type (2019-2030)
    Figure 56. Global Sexual Dysfunction Drugs Price (USD/Pcs) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Sexual Dysfunction Drugs by User (2019-2030)
    Figure 58. Global Revenue Market Share of Sexual Dysfunction Drugs by User (2019-2030)
    Figure 59. Global Sexual Dysfunction Drugs Price (USD/Pcs) by User (2019-2030)
    Figure 60. Sexual Dysfunction Drugs Value Chain
    Figure 61. Sexual Dysfunction Drugs Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS